+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Postoperative local fractionated radiotherapy for resected single brain metastases



Postoperative local fractionated radiotherapy for resected single brain metastases



Strahlentherapie und Onkologie 194(12): 1163-1170



Evaluation of postoperative fractionated local 3D-conformal radiotherapy (3DRT) of the resection cavity in brain metastases. Between 2011 and 2016, 57 patients underwent resection of a single, previously untreated (37/57, 65%) or recurrent (20/57, 35%) brain metastasis (median maximal diameter 3.5 cm [1.1-6.5 cm]) followed by 3DRT. For definition of the gross tumor volume (GTV), the resection cavity was used and for the clinical target volume (CTV), margins of 1.0-1.5 cm were added. Median dose was 48.0 Gy (30.0-50.4 Gy) in 25 (10-28) fractions; most patients had 36.0-42.0 Gy in 3.0 Gy fractions (n = 16, EQD210Gy 39.0-45.5 Gy) or 40.0-50.4 Gy in 1.8-2.0 Gy fractions (n = 37, EQD210Gy 39.3-50.0 Gy). Median follow-up was 18 months. Local control rates were 83% at 1 year and 78% at 2 years and were significantly influenced by histology (breast cancer 100%, non-small lung cancer 87%, melanoma 80%, colorectal cancer 26% at 2 years, p = 0.006) and resection status (p < 0.0001), but not by EQD210Gy or size of the planning target volume (median 96.7 ml [16.7-282.8 ml]). At 1 and 2 years, 74% and 52% of the patients were free from distant brain metastases. Salvage procedures were applied in 25/27 (93%) of recurrent patients. Survival was 68% at 1 year and 41% at 2 years and was significantly improved in younger patients (p = 0.006) with higher Karnofsky performance score (p < 0.0001) and without prior radiotherapy (54% vs. 9% at 2 years, p = 0.006). No cases of radiographic or symptomatic radionecrosis were observed. Adjuvant fractionated local 3DRT is highly effective in radiosensitive, completely resected metastases and should be considered for treating large resection cavities as an alternative to postoperative stereotactic single dose or hypofractionated radiosurgery.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065883162

Download citation: RISBibTeXText

PMID: 30218137

DOI: 10.1007/s00066-018-1368-1


Related references

Local progression and pseudo progression after single fraction or fractionated stereotactic radiotherapy for large brain metastases. A single centre study. Strahlentherapie und Onkologie 188(8): 696-701, 2012

Postoperative Fractionated Stereotactic Radiosurgery to the Tumor Bed for Surgically Resected Brain Metastases. Cureus 9(5): E1279, 2017

Postoperative Management of Resected Brain Metastases: When Can Radiotherapy Be Deferred?. Journal of Clinical Oncology 2018: Jco2018793232, 2018

Postoperative hypofractionated stereotactic brain radiation (HSRT) for resected brain metastases: improved local control with higher BED 10. Journal of Neuro-Oncology 139(2): 449-454, 2018

Single-dose versus fractionated stereotactic radiotherapy for brain metastases. International Journal of Radiation Oncology Biology Physics 81(2): 483-489, 2011

Evaluation of Stereotactic Radiotherapy of the Resection Cavity After Surgery of Brain Metastases Compared to Postoperative Whole-Brain Radiotherapy (ESTRON)-A Single-Center Prospective Randomized Trial. Neurosurgery 83(3): 566-573, 2018

Postoperative radiotherapy for single brain metastases. JAMA 281(18): 1695; Author Reply 1696, 1999

Local recurrence patterns after postoperative stereotactic radiation surgery to resected brain metastases: A quantitative analysis to guide target delineation. Practical Radiation Oncology 8(6): 388-396, 2018

The Role of Postoperative Radiotherapy after Resection of Single Brain Metastases. Neurosurgery 24(6): 798-805, 1989

The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery 24(6): 798-805, 1989

Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resection. Radiation Oncology 11: 76, 2016

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280(17): 1485-1489, 1998

Role of Adjuvant Postoperative Radiotherapy in the Management of Single Brain Metastases: An Analysis of 404 Patients. Neurosurgery 57(2): 410-411, 2005

A randomized prospective trial of the benefit of postoperative radiotherapy in the treatment of single metastases to the brain. International Journal of Radiation Oncology*biology*physics 42(1-Supp-S1): 196-0, 1998

Do We Need to Dose-Escalate Fractionated Stereotactic Radiation Therapy for Resected Brain Metastases?. International Journal of Radiation Oncology*biology*physics 99(2): E519-E520, 2017